Goldman Sachs’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Sell |
466,767
-442,297
| -49% | -$1.8M | ﹤0.01% | 4569 |
|
|
2025
Q4 | $5.87M | Buy |
909,064
+513,914
| +130% | +$3.2M | ﹤0.01% | 3600 |
|
|
2025
Q3 | $2.21M | Sell |
395,150
-129,535
| -25% | -$560K | ﹤0.01% | 4385 |
|
|
2025
Q2 | $1.74M | Sell |
524,685
-294,164
| -36% | -$844K | ﹤0.01% | 4288 |
|
|
2025
Q1 | $2.37M | Sell |
818,849
-57,688
| -7% | -$175K | ﹤0.01% | 4005 |
|
|
2024
Q4 | $3.12M | Buy |
876,537
+653,850
| +294% | +$3.02M | ﹤0.01% | 3917 |
|
|
2024
Q3 | $1.11M | Buy |
222,687
+108,678
| +95% | +$423K | ﹤0.01% | 4565 |
|
|
2024
Q2 | $296K | Sell |
114,009
-412,413
| -78% | -$1.38M | ﹤0.01% | 5111 |
|
|
2024
Q1 | $2.24M | Buy |
526,422
+495,923
| +1,626% | +$1.65M | ﹤0.01% | 3783 |
|
|
2023
Q4 | $61.6K | Buy |
+30,499
| New | +$53.9K | ﹤0.01% | 5355 |
|
|
2023
Q3 | – | Sell |
-57,149
| Closed | -$94.3K | – | 5526 |
|
|
2023
Q2 | $94.3K | Buy |
+57,149
| New | +$103K | ﹤0.01% | 5366 |
|
|
2022
Q4 | – | Sell |
-27,704
| Closed | -$32K | – | 5970 |
|
|
2022
Q3 | $32K | Buy |
27,704
+13,545
| +96% | +$15.3K | ﹤0.01% | 5849 |
|
|
2022
Q2 | $9K | Sell |
14,159
-34,153
| -71% | -$45.4K | ﹤0.01% | 6281 |
|
|
2022
Q1 | $126K | Sell |
48,312
-8,995
| -16% | -$26.3K | ﹤0.01% | 6032 |
|
|
2021
Q4 | $223K | Sell |
57,307
-15,858
| -22% | -$79.6K | ﹤0.01% | 5833 |
|
|
2021
Q3 | $319K | Buy |
73,165
+5,135
| +8% | +$20.1K | ﹤0.01% | 5458 |
|
|
2021
Q2 | $270K | Buy |
68,030
+21,204
| +45% | +$84.7K | ﹤0.01% | 5577 |
|
|
2021
Q1 | $243K | Sell |
46,826
-4,341
| -8% | -$23.1K | ﹤0.01% | 5546 |
|
|
2020
Q4 | $274K | Sell |
51,167
-29,160
| -36% | -$175K | ﹤0.01% | 4933 |
|
|
2020
Q3 | $390K | Buy |
80,327
+60,476
| +305% | +$395K | ﹤0.01% | 4608 |
|
|
2020
Q2 | $96K | Buy |
+19,851
| New | +$91.4K | ﹤0.01% | 5001 |
|
|
2020
Q1 | – | Sell |
-48,336
| Closed | -$281K | – | 5196 |
|
|
2019
Q4 | $281K | Buy |
48,336
+38,127
| +373% | +$198K | ﹤0.01% | 4777 |
|
|
2019
Q3 | $32K | Buy |
+10,209
| New | +$38.3K | ﹤0.01% | 5080 |
|
|
2019
Q2 | – | Sell |
-40,160
| Closed | -$278K | – | 5112 |
|
|
2019
Q1 | $278K | Buy |
40,160
+19,265
| +92% | +$135K | ﹤0.01% | 4664 |
|
|
2018
Q4 | $132K | Sell |
20,895
-559
| -3% | -$7.06K | ﹤0.01% | 4945 |
|
|
2018
Q3 | $376K | Buy |
+21,454
| New | +$354K | ﹤0.01% | 4575 |
|
Other funds holding AQST
BCM
RI
VCM
SB
